Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives

Lung cancer remains the leading cause of cancer-associated mortality worldwide, but with the emergence of oncogene targeted therapies, treatment options have tremendously improved. Owing to their biological relevance, members of the ERBB receptor family, including the EGF receptor (EGFR), HER2, HER3...

Descripción completa

Detalles Bibliográficos
Autores principales: Boch, Tobias, Köhler, Jens, Janning, Melanie, Loges, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724226/
https://www.ncbi.nlm.nih.gov/pubmed/36476337
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724226/
https://www.ncbi.nlm.nih.gov/pubmed/36476337
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0540

Ejemplares similares